Trial
NCT01305395
Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Minnesota
Collaborators
—
Condition
Cardiac Allograft Vasculopathy
Intervention
Sirolimus
Why stopped
Due in part, to reduced transplant volume and enrollment has been difficult.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-24